World News | Agence France-Presse | Thursday October 28, 2021
Treating high-risk Covid-19 patients with the antidepressant fluvoxamine may reduce the risk of prolonged hospitalisation by up to a third, a large-scale study showed Thursday.
www.ndtv.com